Intestinal Mucosal Atrophy: Causes, Symptoms & Treatment

What is Intestinal Mucosal Atrophy?

Intestinal mucosal atrophy describes the pathological thinning and degeneration of the intestinal mucosa -- the innermost lining of the gut. This lining is made up of highly specialized epithelial cells responsible for absorbing nutrients, water, and electrolytes, while simultaneously acting as a barrier against pathogens and toxins. When atrophy occurs, both the structural integrity and the functional capacity of this layer are significantly reduced, with serious consequences for digestion and immune defense.

Causes

Intestinal mucosal atrophy can arise from a range of underlying conditions and factors:

• Malnutrition and undernutrition: Prolonged deficiency of macro- and micronutrients reduces the regenerative capacity of mucosal cells.
• Total parenteral nutrition (TPN): When the gut is bypassed by intravenous feeding, the absence of luminal stimulation leads to progressive mucosal atrophy.
• Coeliac disease: An immune-mediated reaction to gluten causes destruction of the intestinal villi in the small bowel.
• Crohn's disease and inflammatory bowel disease (IBD): Chronic inflammation damages the mucosal architecture over time.
• Infections: Certain parasites (e.g., Giardia lamblia), bacteria, and viruses can cause significant mucosal damage.
• Radiation therapy: Abdominal or pelvic radiation destroys rapidly dividing intestinal epithelial cells.
• Chemotherapy: Cytotoxic drugs target fast-dividing cells, including the mucosal epithelium, leading to mucositis and atrophy.
• Critical illness and sepsis: Reduced intestinal perfusion during severe systemic illness can trigger ischaemic mucosal damage.

Symptoms

The clinical presentation depends on the extent and location of the mucosal damage:

• Chronic diarrhoea and loose or watery stools
• Malabsorption of vitamins (e.g., B12, D, K), minerals, and proteins
• Unintentional weight loss and muscle wasting
• Bloating, abdominal cramps, and flatulence
• Anaemia due to iron or vitamin B12 deficiency
• Impaired immune function caused by a weakened gut barrier
• In severe cases: increased intestinal permeability (leaky gut syndrome), allowing bacteria and endotoxins to enter the bloodstream

Diagnosis

Diagnosis typically involves a combination of the following approaches:

• Endoscopy with biopsy: The gold standard for assessing mucosal structure; tissue samples are evaluated histologically for villous atrophy and crypt hyperplasia.
• Histopathology: Microscopic grading of mucosal damage, for example using the Marsh classification in coeliac disease.
• Blood tests: Detection of nutritional deficiencies (albumin, vitamin B12, folate, iron, zinc) and inflammatory markers.
• Stool tests: Assessment of fat malabsorption (steatorrhoea), infectious agents, or inflammatory markers such as faecal calprotectin.
• Imaging: Abdominal MRI or CT to evaluate bowel wall thickness and inflammatory changes.

Treatment

Treatment is directed at the underlying cause and aims to restore mucosal integrity and nutritional status:

Nutritional Therapy

Enteral nutrition (feeding via the gastrointestinal tract) is always preferred over parenteral nutrition when feasible, as luminal nutrients provide direct stimulation and trophic support to the intestinal mucosa. High-calorie, nutrient-dense formulas can promote mucosal regeneration.

Key Nutrients for Mucosal Repair

Specific nutrients play a critical role in the recovery of the intestinal lining:

• Glutamine: The primary energy substrate for intestinal epithelial cells; supplementation may benefit critically ill patients.
• Zinc: Essential for cell division and wound healing of the mucosa.
• Vitamin A: Supports the differentiation and integrity of epithelial cells.
• Probiotics and prebiotics: May help restore gut microbiota balance and support mucosal healing.

Treatment of the Underlying Condition

• For coeliac disease: A strict gluten-free diet leads to progressive regeneration of the intestinal villi.
• For IBD: Medical treatment with immunosuppressants, corticosteroids, or biologics.
• For infections: Targeted antibiotic or antiparasitic therapy.
• For radiation-induced damage: Supportive care and specialised nutritional management.

Prognosis

The outlook for intestinal mucosal atrophy depends largely on the underlying cause and how early treatment is initiated. In coeliac disease, the mucosa often regenerates fully with adherence to a gluten-free diet. In other conditions, ongoing medical management is required to prevent nutritional deficiencies and maintain quality of life.

References

1. Ludvigsson, J.F. et al. - Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut, 63(8):1210-1228 (2014). DOI: 10.1136/gutjnl-2013-306578.
2. Buchman, A.L. et al. - Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. Journal of Parenteral and Enteral Nutrition, 19(6):453-460 (1995). PubMed PMID: 8748361.
3. World Health Organization (WHO) - Nutritional anaemias: tools for effective prevention and control. WHO Press, Geneva (2017). Available at: https://www.who.int.